Following diagnosis of breast cancer, patients are stratified based on expression of estrogen receptor alpha (ERα), progesterone receptor (PR), and amplification of the human epidermal growth factor receptor 2 (HER2) gene. This evidence concerns the gene ERBB2 and breast carcinoma.